Salix Pharmaceuticals Ltd
Q2 2014 13F Holders
Symbol
SLXP
CUSIP
795435106
Type
Equity
Class
COM
Num filings
335
Total reported value, excl. options
$8.48 B
Compare 2014 Q2 to
2016 Q1
2015 Q4
2015 Q2
2015 Q1
2014 Q4
2014 Q3
2014 Q1
Manager
Report Date
Value ($000)
Shares
Option Type